Table 1.
Clinical characteristics of patients with juvenile rheumatoid arthritis
Parameter | Systemic onset JRA (n = 20) | Polyarticular JRA (n = 16) or pauciarticular JRA (n = 4) |
Male/female | 9/11 | 14/6 |
Mean age, years (range) | 11.5 (2–23) | 12.8 (3–22) |
Mean disease duration, years (range) | 4.1 (0.2–16) | 5.8 (0.9–15) |
No. with active arthritis (%) | 17 (85) | 17 (85) |
No. with active systemic disease (%) | 8 (40) | - |
Mean ESR, mm/h (range) | 30 (5–85) | 21 (5–57) |
No. (%) receiving | ||
Prednisone | 6 (30) | 3 (15) |
Methotrexate | 12 (60) | 10 (50) |
TNF-blocking agent | 3 (15) | 5 (25) |
Intra-articular steroids | 1 (5) | 4 (20) |
NSAID | 17 (85) | 18 (90) |
ESR, erythrocyte sedimentation rate; JRA, juvenile rheumatoid arthritis; NSAID, non-steroidal anti-inflammatory drugs; TNF, tumor necrosis factor.